argenx SE reported $404.12M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
AstraZeneca USD 5.67B 1.29B Mar/2026
Genmab DKK 186M 291M Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
GRIFOLS EUR 347.45M 210K Dec/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Qiagen NV USD 249.69M 56.53M Dec/2025
UCB EUR 1.6B 570M Dec/2025